The present disclosure relates to crystalline forms of [1-cyano-5-(4-chlorophenoxy)-4-hydroxy-isoquinoline-3-carbonyl]-amino}-acetic acid (Compound A), the process of preparing crystalline forms of Compound A, the pharmaceutical compositions containing them, and the methods of use thereof.
本公开涉及[1-
氰基-5-(
4-氯苯氧基)-
4-羟基异喹啉-3-羧酰基]-
氨基}
乙酸(化合物A)的晶体形式,制备化合物A晶体形式的过程,含有其的制药组合物以及使用它们的方法。